KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Interest Coverage Ratio (2017 - 2025)

Aquestive Therapeutics has reported Interest Coverage Ratio over the past 9 years, most recently at 10.38 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 10.38 for Q4 2025, down 112.46% from a year ago — trailing twelve months through Dec 2025 was 6.39 (down 130.94% YoY), and the annual figure for FY2025 was 6.39, down 130.94%.
  • Interest Coverage Ratio for Q4 2025 was 10.38 at Aquestive Therapeutics, down from 4.13 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for AQST hit a ceiling of 0.02 in Q2 2024 and a floor of 10.38 in Q4 2025.
  • Median Interest Coverage Ratio over the past 5 years was 3.65 (2024), compared with a mean of 4.36.
  • Biggest five-year swings in Interest Coverage Ratio: surged 100.65% in 2024 and later crashed 20754.23% in 2025.
  • Aquestive Therapeutics' Interest Coverage Ratio stood at 6.69 in 2021, then rose by 2.96% to 6.49 in 2022, then skyrocketed by 73.5% to 1.72 in 2023, then crashed by 183.98% to 4.89 in 2024, then tumbled by 112.46% to 10.38 in 2025.
  • The last three reported values for Interest Coverage Ratio were 10.38 (Q4 2025), 4.13 (Q3 2025), and 4.09 (Q2 2025) per Business Quant data.